4:30 PM
 | 
Apr 15, 2014
 |  BC Extra  |  Politics & Policy

FDA reschedules risk-benefit assessment meeting

FDA rescheduled for May 12 a public meeting to be held with Institute of Medicine (IOM)...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >